Zum Hauptinhalt springen

Icariin Alleviates Escherichia coli Lipopolysaccharide-Mediated Endometritis in Mice by Inhibiting Inflammation and Oxidative Stress.

Shaukat, A ; Shaukat, I ; et al.
In: International journal of molecular sciences, Jg. 23 (2022-09-06), Heft 18
Online academicJournal

Titel:
Icariin Alleviates Escherichia coli Lipopolysaccharide-Mediated Endometritis in Mice by Inhibiting Inflammation and Oxidative Stress.
Autor/in / Beteiligte Person: Shaukat, A ; Shaukat, I ; Rajput, SA ; Shukat, R ; Hanif, S ; Huang, S ; Aleem, MT ; Li, K ; Li, Q ; Chen, C ; Zhang, X ; Lv, H ; Yao, Z ; Yang, L
Link:
Zeitschrift: International journal of molecular sciences, Jg. 23 (2022-09-06), Heft 18
Veröffentlichung: Basel, Switzerland : MDPI, [2000-, 2022
Medientyp: academicJournal
ISSN: 1422-0067 (electronic)
DOI: 10.3390/ijms231810219
Schlagwort:
  • Animals
  • Anti-Inflammatory Agents pharmacology
  • Antioxidants metabolism
  • Catalase metabolism
  • Cytokines metabolism
  • Escherichia coli metabolism
  • Female
  • Flavonoids
  • Glutamate-Cysteine Ligase metabolism
  • Heme Oxygenase-1 metabolism
  • Humans
  • Inflammation drug therapy
  • Interleukin-10 metabolism
  • Interleukin-6 metabolism
  • Malondialdehyde
  • Mice
  • NAD metabolism
  • NF-E2-Related Factor 2 metabolism
  • NF-kappa B metabolism
  • Oxidative Stress
  • Quinones pharmacology
  • RNA, Messenger metabolism
  • Reactive Oxygen Species metabolism
  • Superoxide Dismutase-1 metabolism
  • Toll-Like Receptor 4 metabolism
  • Tumor Necrosis Factor-alpha metabolism
  • Endometritis chemically induced
  • Endometritis drug therapy
  • Lipopolysaccharides adverse effects
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article
  • Language: English
  • [Int J Mol Sci] 2022 Sep 06; Vol. 23 (18). <i>Date of Electronic Publication: </i>2022 Sep 06.
  • MeSH Terms: Endometritis* / chemically induced ; Endometritis* / drug therapy ; Lipopolysaccharides* / adverse effects ; Animals ; Anti-Inflammatory Agents / pharmacology ; Antioxidants / metabolism ; Catalase / metabolism ; Cytokines / metabolism ; Escherichia coli / metabolism ; Female ; Flavonoids ; Glutamate-Cysteine Ligase / metabolism ; Heme Oxygenase-1 / metabolism ; Humans ; Inflammation / drug therapy ; Interleukin-10 / metabolism ; Interleukin-6 / metabolism ; Malondialdehyde ; Mice ; NAD / metabolism ; NF-E2-Related Factor 2 / metabolism ; NF-kappa B / metabolism ; Oxidative Stress ; Quinones / pharmacology ; RNA, Messenger / metabolism ; Reactive Oxygen Species / metabolism ; Superoxide Dismutase-1 / metabolism ; Toll-Like Receptor 4 / metabolism ; Tumor Necrosis Factor-alpha / metabolism
  • References: Oncotarget. 2017 Mar 21;8(12):20042-20055. (PMID: 28223539) ; Microb Pathog. 2020 Jun;143:104109. (PMID: 32171710) ; Nat Immunol. 2011 Nov 20;13(1):29-34. (PMID: 22101731) ; Front Immunol. 2018 Aug 22;9:1916. (PMID: 30186287) ; Toxicology. 2007 Feb 12;230(2-3):197-206. (PMID: 17188792) ; BMC Complement Altern Med. 2019 Nov 19;19(1):316. (PMID: 31744482) ; Molecules. 2021 Nov 23;26(23):. (PMID: 34885671) ; Int Immunopharmacol. 2015 Sep;28(1):695-9. (PMID: 26256698) ; J Cell Physiol. 2020 May;235(5):4766-4777. (PMID: 31674024) ; Clin Chest Med. 2005 Mar;26(1):105-12. (PMID: 15802172) ; Pharmacol Res. 2005 Aug;52(2):174-82. (PMID: 15967384) ; Exp Ther Med. 2021 Jan;21(1):72. (PMID: 33365072) ; Antioxidants (Basel). 2021 Aug 09;10(8):. (PMID: 34439516) ; Microb Pathog. 2019 Dec;137:103767. (PMID: 31580956) ; Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1029-37. (PMID: 11076792) ; Can J Physiol Pharmacol. 2015 Nov;93(11):967-71. (PMID: 26426600) ; J Agric Food Chem. 2016 Aug 10;64(31):6171-8. (PMID: 27411287) ; Inflammation. 2018 Oct;41(5):1702-1716. (PMID: 29987481) ; Int J Clin Exp Pathol. 2015 Sep 01;8(9):10929-34. (PMID: 26617809) ; Pharmacol Biochem Behav. 2005 Dec;82(4):686-94. (PMID: 16380159) ; J Zhejiang Univ Sci B. 2019 Oct.;20(10):816-827. (PMID: 31489801) ; Int Immunopharmacol. 2010 Jun;10(6):668-78. (PMID: 20347053) ; Int Immunopharmacol. 2019 Aug;73:304-311. (PMID: 31128530) ; Eur J Pharmacol. 2010 Sep 10;642(1-3):146-53. (PMID: 20519138) ; Inflammation. 2013 Feb;36(1):242-50. (PMID: 22968433) ; Inflammation. 2021 Oct;44(5):1683-1695. (PMID: 33907916) ; Mater Sociomed. 2015 Jun;27(3):149-53. (PMID: 26244043) ; Atherosclerosis. 2005 Mar;179(1):51-9. (PMID: 15721009) ; Mol Immunol. 2018 Feb;94:7-17. (PMID: 29241031) ; Microb Pathog. 2019 Jul;132:302-312. (PMID: 31059756) ; Inflamm Res. 2019 Mar;68(3):231-240. (PMID: 30673803) ; Innate Immun. 2020 Feb;26(2):97-106. (PMID: 31390916) ; Clin Exp Immunol. 2007 Feb;147(2):227-35. (PMID: 17223962) ; Free Radic Biol Med. 2016 Apr;93:52-66. (PMID: 26845617) ; Sci Rep. 2017 Aug 10;7(1):7760. (PMID: 28798396) ; Microb Pathog. 2018 Oct;123:139-143. (PMID: 29928944) ; Int Immunopharmacol. 2017 May;46:194-200. (PMID: 28315822) ; Mol Biosyst. 2017 Jan 31;13(2):392-405. (PMID: 28070584) ; Mol Vis. 2011 Apr 06;17:854-63. (PMID: 21527993) ; Oxid Med Cell Longev. 2021 Dec 31;2021:5042048. (PMID: 35003515) ; Biochem Biophys Res Commun. 2008 Nov 14;376(2):404-8. (PMID: 18789310) ; Ecotoxicol Environ Saf. 2021 Aug;219:112353. (PMID: 34034046) ; Stem Cells Dev. 2008 Aug;17(4):751-60. (PMID: 18484897) ; Planta Med. 1997 Aug;63(4):316-9. (PMID: 9270375) ; Int Immunopharmacol. 2019 May;70:201-207. (PMID: 30822611) ; Ecotoxicol Environ Saf. 2021 Sep 1;220:112333. (PMID: 34058674) ; Inflammation. 2020 Apr;43(2):579-594. (PMID: 31845052) ; Oxid Med Cell Longev. 2018 Jan 31;2018:6717212. (PMID: 29636853) ; J Clin Invest. 2001 Jan;107(1):7-11. (PMID: 11134171) ; Int Immunopharmacol. 2018 Nov;64:140-150. (PMID: 30173054) ; Int J Biol Sci. 2021 Mar 25;17(5):1289-1301. (PMID: 33867846) ; Biomed Pharmacother. 2019 Dec;120:109567. (PMID: 31670031) ; J Inflamm Res. 2021 Jul 05;14:2963-2978. (PMID: 34262322)
  • Grant Information: CARS36 China Agriculture Research System of MOF and MAR and earmarked fund for CARS36
  • Contributed Indexing: Keywords: NF-κB and Nrf2 pathway; TLR4; endometritis; icariin; lipopolysaccharide
  • Substance Nomenclature: 0 (Anti-Inflammatory Agents) ; 0 (Antioxidants) ; 0 (Cytokines) ; 0 (Flavonoids) ; 0 (Interleukin-6) ; 0 (Lipopolysaccharides) ; 0 (NF-E2-Related Factor 2) ; 0 (NF-kappa B) ; 0 (Quinones) ; 0 (RNA, Messenger) ; 0 (Reactive Oxygen Species) ; 0 (Toll-Like Receptor 4) ; 0 (Tumor Necrosis Factor-alpha) ; 0U46U6E8UK (NAD) ; 130068-27-8 (Interleukin-10) ; 4Y8F71G49Q (Malondialdehyde) ; EC 1.11.1.6 (Catalase) ; EC 1.14.14.18 (Heme Oxygenase-1) ; EC 1.15.1.1 (Superoxide Dismutase-1) ; EC 6.3.2.2 (Glutamate-Cysteine Ligase) ; VNM47R2QSQ (icariin)
  • Entry Date(s): Date Created: 20220923 Date Completed: 20220926 Latest Revision: 20230308
  • Update Code: 20231215
  • PubMed Central ID: PMC9499631

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -